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Cerebrospinal fluid samples from five patients from which Candida cells were cultured were tested for the
presence of mannan. Samples from four patients categorized as having proven candidosis reacted positively.
Samples from the remaining patient and from patients with other central nervous system infections were
negative. Detection of mannan may be valuable in the diagnosis of Candida meningitis.
Meningitis caused by Candida infection is a rare and diffi-
cult-to-diagnose infectious disease. A substantial proportion is
found among very-low-birth-weight neonates (13), but Can-
dida meningitis has been found also in human immunodefi-
ciency virus-infected patients (8, 30) and patients with ventric-
ular shunts or after lumbar puncture (5, 31). The most frequent
symptoms are headache, photophobia, nuchal rigidity, and de-
lirium, but an indolent course is also possible. The cerebrospi-
nal fluid (CSF) usually shows a pleocytosis predominated by
neutrophils and mononuclear cells, an elevated protein con-
centration, and a normal or low glucose concentration. The
sensitivity of CSF cultures is low because the number of fungal
cells in the CSF is small. Therefore, large volumes, preferably
more than 5 ml, should be cultured (23). A delay in diagnosis
and subsequent treatment is considered to be associated with a
poor prognosis (4). Additionally, the significance of a positive
culture from the CSF may be unclear. Contamination of the
CSF sample may occur because of colonization of the skin or
when cultures have been taken from external reservoirs that
contain CSF. Several non-culture-based methods have been
developed for diagnosing invasive fungal infections of the
CNS, such as cryptococcal meningitis (10, 16, 18) and CNS
aspergillosis (32, 33). Similarly, a Candida cell wall component,
mannan, has been used as a target for serological tests. Al-
though the detection of circulating mannan was found to be of
limited value in the diagnosis of invasive candidosis, detection
of mannan in CSF could be a valuable tool for diagnosing CNS
candidosis. Here, we report on five patients who were treated
for CNS candidosis and for whom we evaluated the diagnostic
value of mannan antigen detection in CSF.
Case 1. A 4-year-old girl was admitted to our hospital be-
cause of a relapse of acute nonlymphatic leukemia for which
she had been treated with chemotherapy in the previous 6
months. Treatment with fluconazole was started because ultra-
sound examination of the abdomen showed dense lesions in
the liver that raised suspicion of chronic disseminated candido-
sis and Candida albicans was cultured from CSF samples. More
CSF samples were taken, and all of them grew C. albicans.
Because of a clinical and microbiological failure of fluconazole,
therapy was switched to amphotericin B lipid complex. The
fever initially resolved but later recurred. Other CSF samples,
collected during amphotericin B lipid complex therapy, again
grew C. albicans. Eventually, she died of hypovolemic shock
due to a hemorrhage. Autopsy was not permitted.
Case 2. A 60-year-old male was admitted to our hospital
because of an organic psychosyndrome. No signs of meningism
were present. He was treated outside The Netherlands with
prednisolone and immuran for suspected lupus erythematosus.
In the preceding months, the course of his disease was com-
plicated by a bowel ischemia that required extensive surgery,
abdominal abscesses, and a Candida endophthalmitis of his left
eye, for which a vitrectomy was performed and oral fluconazole
was started. Culture of a CSF sample yielded C. albicans.
Treatment with fluconazole and flucytosine was started. Re-
peated CSF cultures still grew C. albicans; therefore, flucon-
azole was replaced with amphotericin B. After an additional 2
weeks of treatment, the patient was discharged while still show-
ing signs of an organic psychosyndrome. Cultures of CSF sam-
ples collected in the course of his treatment remained sterile,
but chemistry still was suggestive of meningitis. Eventually, he
was lost to follow-up.
Case 3. A 48-year-old male with dermatomyositis and
treated with prednisone and immuran, was readmitted to the
hospital with fever, dysarthria, persistent uveitis, and head-
ache. Culture of a CSF sample yielded C. albicans, C. parapsi-
losis, and C. guilliermondii. Repeat cultures were positive for
C. albicans and C. parapsilosis. Treatment with fluconazole was
started. The patient was discharged from the hospital while
undergoing oral fluconazole therapy, but he had to be read-
mitted several weeks later with a clinical relapse of meningitis.
Despite sterile CSF cultures, chemical analysis was suggestive
of infection. Fluconazole was replaced with amphotericin B
and flucytosine for 2 weeks, which resulted in a clinical im-
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provement and a decrease in CSF neutrophils. The patient was
discharged while undergoing therapy with oral fluconazole
combined with flucytosine and remained free of clinical
symptoms.
Case 4. A dysmature and premature female neonate (birth
weight, 700 g; born at 26 weeks of gestation) was admitted to
the neonatal intensive care unit. She became septic on day 4;
therefore, antibiotic therapy was started. A sepsis workup was
performed that included a lumbar puncture on day 11. Culture
of the CSF sample obtained showed C. albicans. Intravenous
fluconazole was started. Three days later, she deteriorated;
therefore, fluconazole was replaced with liposomal amphoter-
icin B. Microscopy of CSF showed yeast cells, but cultures
remained sterile. Gradually, the clinical condition improved.
Eventually, she could be transferred to a pediatric ward in
stable condition.
Case 5. A 76-year-old female was admitted because of a
relapse of a retroauricular basal cell carcinoma. The tumor was
surgically removed, and an intraspinal catheter was placed in
order to facilitate monitoring of the pressure in the subarach-
noid space. Postoperatively, the patient appeared to have a
left-sided hemiparesis, a facialis paresis, and dysarthria but no
signs of meningism. A culture of CSF collected shortly after
surgery remained sterile. A second postoperative CSF sample
grew C. albicans. Chemical analysis showed no evidence of
infection besides an elevated protein level. Repeat CSF col-
lection showed a decrease in the protein level, and cultures
were sterile. Her neurological deficits were already improving.
Nevertheless, treatment with fluconazole was started. Cultures
of two additional CSF samples remained sterile. After 14 days
of treatment, she was transferred to a nursing home. She died
several months later because of complications of local tumor
growth. Retrospectively, the positive CSF culture was consid-
ered to be contaminated.
CSF samples were processed at the microbiology laboratory
within 8 h of collection. They were centrifuged at 10,000  g
for 10 min. The sediment was stained with Gram’s stain, meth-
ylene blue, and calcofluor white or Uvitex 2B for direct mi-
croscopy. In addition to bacterial cultures, the CSF sediment
was plated onto Sabouraud glucose medium, inoculated into
Sabouraud broth, and incubated at 30°C for 3 weeks. Blood
samples were cultured by using the BacTec system (Becton
Dickinson, Cockeysville, Md.). To test the specificity of the
mannan detection in CSF, three control groups were used.
Group A included 28 CSF samples from patients with clinically
suspected bacterial meningitis and negative fungal cultures.
Group B included 10 CSF samples from seven patients with
culture-proven cryptococcal meningitis and a positive crypto-
coccal antigen test result. Group C included 16 CSF samples
from 10 patients with CNS aspergillosis that were positive for
Aspergillus antigen.
Mannan detection. Serum and CSF samples were stored at
80°C before use. Detection of mannan was performed with a
commercial enzyme-linked immunosorbent assay (ELISA)
(Platelia Candida; Bio-Rad, Marnes-La-Coquette, France) in
accordance with the manufacturer’s instructions. The mean
optical density (OD) and standard deviation were calculated
for the 28 control CSF samples in group A. The cutoff value for
a positive CSF sample was defined as the mean OD plus five
times the standard deviation. For serum, a standard curve was
constructed by using standard sera with 0.25, 0.5, 1.0, and 2.0
ng/ml. The OD was interpreted as follows: 0.25 ng/ml was
considered negative, 0.25 and 0.5 ng/ml was considered
intermediate, and 0.5 ng/ml was considered positive.
Aspergillus antigen detection. A commercial sandwich ELISA
(Platelia Aspergillus) was used to detect the Aspergillus antigen
galactomannan. ODs were measured at 450 and 625 nm. The
ratio of the ODs of the sample mixture and the weakly positive
sample were calculated for each sample, and a ratio larger than
0.6 was considered positive, as has been described previously
(32).
The results of culture and mannan detection in the CSF
samples are shown in Table 1. Of CSF samples from control
patients with bacterial meningitis (group A), six were culture
positive (Pseudomonas aeruginosa, Neisseria meningitidis, Staph-
ylococcus epidermidis, S. aureus, an unspecified gram-positive
rod, and a gram-negative rod). Cryptococcus antigen was de-
tected in all 10 CSF samples from patients with Cryptococcus
meningitis (group B), and Aspergillus antigen was detected in
all 16 samples from patients with CNS aspergillosis (group C).
However, none of these control samples showed reactivity with
the mannan ELISA, indicating absence of cross-reactivity of
the mannan ELISA with Cryptococcus and Aspergillus antigen
or with other putatively present microbial antigens (Table 1).
TABLE 1. Results of detection of Candida mannan in CSF compared with culture
Case no. or
group Classification
a Culture resultb
(no. positive/total)
Mean OD
(range)
Interpretationc
(no. positive/total)
1 Proven infection 4/4 2.999d 3/3
2 Proven infection 2/5 0.571 (0.489–0.779) 7/7
3 Proven infection 3/9 1.721 (1.057–2.935) 4/4
4 Proven infection 1/2 3.500d 2/2
5 No infection 1/6 0.297 (0.259–0.331) 0/3
Ae Control 0/28 0.264 (0.211–0.365) 0/28
B Control 10/10 0.163 (0.112–0.228) 0/10
C Control 0/16 0.211 (0.160–0.270) 0/16
a Based on criteria adapted from reference 3.
b Culture for yeasts.
c Cutoff value  0.440.
d ODs out of range.
e Control group: A, patients with clinically suspected bacterial meningitis and negative fungal cultures; B, patients with cultures positive for C. neoformans and CSF
positive for cryptococcal antigen; C, patients CSF positive for Aspergillus antigen.
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Mannan was detected in the CSF in all four cases of proven
CNS candidosis. In the fifth patient, CNS candidosis was un-
likely and mannan was not detected.
Mannan or mannoprotein is the immunodominant surface
antigen of C. albicans serotypes A and B. Although this antigen
is known to circulate in blood during systemic infection (22),
the results of antigen detection in serum have been variable,
with sensitivities ranging from 0 to 100% and specificities rang-
ing from 88 to 100%, depending on the patient category tested,
the type of assay used, and the number of samples collected (3,
7, 9, 17, 20, 24–26, 28, 29, 34). To our knowledge, detection of
mannan in CSF has been used once before in the diagnosis and
follow-up of treatment of Candida meningitis (14). Antigen
was detected in CSF samples from four of the five patients
described in this report. These patients can be categorized as
having proven invasive Candida infection, according to con-
sensus definitions (2). For yeast infections, these criteria prob-
ably can also be applied to patient categories other than cancer
and hematological malignancies, as described in cases 2 to 5.
Although our patients probably acquired meningitis hematog-
enously, not a single blood culture grew yeast. In the first two
patients, circulating antigen was not detected in blood at the
time of mannan detection in the CSF. Although the kinetics of
mannan in CSF are unknown, we think that leakage of mannan
from the circulation to the CSF is unlikely on the basis of these
observations.
Only one of a series of five CSF samples from the fifth
patient showed C. albicans in culture, yet chemical analysis
showed improvement compared with the analysis performed
on the first sample. Similar patterns have been observed in
cases with shunts or other devices in the subarachnoid space, in
which there appeared to be no meningitis and in which only a
single CSF sample was positive for yeasts (11). An explanation
for the repeatedly negative results of the ELISA performed on
the CSF samples of this patient thus could be that there was no
meningitis but a contamination of the single CSF sample that
grew C. albicans. Therefore, these results suggest that the
detection of mannan in CSF may help to differentiate between
Candida meningitis and contamination. This is supported by
the observed high specificity (100%) of the test used here. The
mannan ELISA consequently showed no reactivity with sam-
ples from patients with infections of the CNS caused by bac-
teria or Cryptococcus or Aspergillus spp.
Detection of fungal antigens in CSF has been described for
cryptococcal infections of the CNS (21) and has value in mon-
itoring the response to treatment of patients with AIDS-asso-
ciated cryptococcal meningitis (27). Previously, our group de-
scribed a case of Aspergillus meningitis in which the Aspergillus
antigen galactomannan was detected 45 days before culture
became positive and the titer declined when effective therapy
was instituted (32). Likewise, detection and monitoring of
mannan in CSF could be useful in Candida meningitis, al-
though the value of monitoring mannan levels in relation to
clinical response to treatment remains unclear since the num-
ber of samples tested was too limited to draw conclusions. One
important issue is whether detection of mannan can also be
used to diagnose CNS infections caused by non-C. albicans
species. Although C. albicans is one of the most frequently
isolated species in CNS infections caused by Candida spp. (4),
other species, like C. tropicalis, (12), C. lusitaniae (19), C.
parapsilosis (6), and C. glabrata (1), have also been encoun-
tered. Although the antimannan antibody EBCA-1, which is
used in the ELISA, is directed against an epitope derived from
C. albicans mannan, this epitope has also been described in
other Candida species like C. tropicalis, C. glabrata, C. para-
psilosis, and C. krusei (15). ELISA reactivity with mannan de-
rived from these species may therefore be expected. However,
the lower limit of detection and therefore the sensitivity may
be different for each species, which already has been observed
in another ELISA (25).
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